Prostate cancer stratification with diverse biologically|informed ...

[2309.16645] Reusability report: Prostate cancer stratification with ...

Abstract page for arXiv paper 2309.16645: Reusability report: Prostate cancer stratification with diverse biologically-informed neural ...

Prostate cancer stratification with diverse biologically-informed ...

We experimented with three types of graph neural networks on the same train- ing data, and investigated the clinical prediction agreement ...

Biologically informed deep neural network for prostate cancer ...

The determination of molecular features that mediate clinically aggressive phenotypes in prostate cancer remains a major biological and ...

Prostate cancer risk stratification improvement across ... - NCBI

Prostate cancer risk stratification using single-nucleotide polymorphisms (SNPs) demonstrates considerable promise in men of European, Asian, ...

Biological Determinants of Health Disparities in Prostate Cancer

Analysis of tumor markers indicates that tumor biological differences may exist between prostate cancer patients of African ancestry and those of European or ...

Prostate Cancer Risk Stratification by Digital Histopathology and ...

Prostate cancer (PCa) represents a highly heterogeneous disease that requires tools to assess oncologic risk and guide patient management ...

Genetics of Prostate Cancer (PDQ®) - NCI

However, when combined into a PRS, these confirmed genetic risk variants may prove to be useful for prostate cancer risk stratification and to ...

Association of Risk Stratification Technologies With Prostate Cancer ...

There have been dramatic recent increases in the acceptance of active surveillance for prostate cancer, a period of close monitoring followed by ...

Prostate Cancer Risk Stratification via Nondestructive 3D Pathology ...

Due to the slow rate of progression for most prostate cancer cases, an initial clinical study to assess the prognostic value of 3D versus 2D glandular features ...

Prostate cancer genotyping for risk stratification and... - LWW

Current therapeutic protocols follow the evolution of PC, a continuously progressive process involving a combination of widespread genomic alterations. These ...

A novel stratification framework for predicting outcome in patients ...

In addition, we develop a stratification framework that incorporates DESNT and identifies three novel molecular subtypes of prostate cancer.

Risk Groups - Prostate Cancer Foundation

Settings · Low risk: Tumor is confined to the prostate, and the PSA is <10 and grade group 1 (Gleason 6). · Intermediate risk: Tumor is confined to the prostate, ...

A Multi-Omics-Focused Approach to Detection and Risk Stratification

Prostate cancer remains a significant health challenge, being the most prevalent non-cutaneous cancer in men worldwide. This review discusses the critical ...

Risk Groups and Lab Tests to Help Determine Risk from Localized ...

Prolaris: This test measures the activity of a different set of genes in prostate cancer cells taken from a biopsy and reports it as a score on ...

Population-Based Comparison of Different Risk Stratification ...

Background: It is not known which risk stratification system has the best discrimination ability for predicting prostate cancer death. Methods: ...

Risk stratification tools in prostate cancer, where do we stand?

In an attempt to predict outcomes and individualize care for prostate cancer (PCa) patients, parallels are drawn between a patient's current health status and ...

Clinically Localized Prostate Cancer: AUA/ASTRO Guideline (2022)

The recommendations discussed herein for the management of clinically localized prostate cancer provide a framework stratified by risk to facilitate care ...

Prostate cancer risk stratification via eNose urine odor analysis

Introduction: Prostate cancer (PCa) is known for its highly diverse clinical behavior, ranging from low-risk, slow-growing tumors to ...

More precise classification of risk in prostate cancer reveals a huge ...

A new study found a wide variation in how men with prostate cancer are managed in different hospitals. Current NICE guidelines recommend that ...

Risk stratification and choice of initial treatment' - UpToDate

Neuroendocrine prostate cancer (NEPC) encompasses various clinical contexts, ranging from the de novo presentation of small cell prostatic carcinoma to a ...